register

News & Trends - Pharmaceuticals

Pharma stands united with governments and global health stakeholders worldwide to combat COVID-19

Health Industry Hub | May 20, 2020 |

Pharma News: At the Seventy-Third World Health Assembly, IFPMA, the industry body representing the innovative biopharmaceutical industry delivered a joint statement on behalf of the global interests of broad innovative health industries, reasserting that they stand united with governments and global health stakeholders worldwide to combat COVID-19.

The biopharmaceutical industry is joined by biotech, self-medication, diagnostic, and medical technology industries committed to the goal of accelerating development, production and equitable global access to safe, quality, effective, and affordable COVID-19 medical products and to ensure that in the fight against COVID-19, no one is left behind.

According to BioCentury, there are nearly 400 potential treatments and vaccines for COVID-19 in development. Much of the current COVID-19 R&D that has been deployed at an unprecedented speed is built upon products, expertise and research capacity that has been refined and developed by the private sector over many years and thanks to an ecosystem that supports innovation, which is underpinned by solid intellectual property rights.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Thomas Cueni, Director General of the IFPMA said “We understand accelerated development and production of new COVID-19 tools is not enough: we must also ensure equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines – making sure no-one is left behind. Biopharmaceutical companies have publicly committed to, and are actively working with, governments, insurers, foundations and international organizations to make future COVID-19 products available and affordable to those that need them”.

As a founding partner of the recently launched ACT Accelerator, IFPMA is rallying around the urgent need for coordinated, inclusive, and multi-stakeholder action as the only possible solution to mitigate the impact of this unprecedented global health emergency, and ensure equitable access to COVID-19 treatments and vaccines.

Thomas Cueni warns that while all eyes are on COVID-19, work to support health systems efforts to meet the health-related SDGs must not be cast aside.

He explains “COVID-19 is cruelly driving home a tough lesson: facing any global health challenge, in particular of such unprecedented scale, requires solidarity and inclusive cooperation. I think there has been a recognition among the broader health community that the industry has reached out, is teaming up and is responding at amazing speed. But at the same time, efforts to ensure essential medicines, vaccines and diagnostics for patients with other life-threatening diseases, must continue”.

You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.